By Josh Farmer, IndyCar Reporter
Charlie Kimball will change numbers and his primary sponsor for the 100th RUnning ofthe Indianapolis 500 presented by Penngarde Motor Oil.
Kimball, the only licenced IndyCar driver with diabetes will run the #42 instead of his traditional #83 as part of a promotional effort with sponsor Novo Nordisk’s new medication Tresiba.
The number change reflects the number of hours that Tresiba works in one’s bloodstream. Tresiba is a long lasting insulin that builds longer strands of insulin molecules so it only has to be injected once a day as apposed to two like most diabetes meciations. The number is also borrowed from Chip Ganassi Racing’s NASCAR Sprint Cup Series driver, Kyle Larson.
“The 100th running of the Indianapolis 500 will be the highlight of this year’s season and it gives me a great opportunity to honor the diabetes community and help inspire those people living with or affected by diabetes,” said Kimball. “As a race car driver and a person living with diabetes, the duration of action of Tresiba is important to me and plays an important role in my management plan. I am honored to represent Novo Nordisk and Chip Ganassi Racing and to share my story with the diabetes community.”
The car will also feature the names of 42 notable names in the diabetes community, including Dominique Wilkins and Billie Jean King.
Image: Chip Ganassi Racing